US Patent Issued to The Trustees of Columbia University in the City of New York on Oct. 14 for "SLC2A1 lncRNA as a biologic and related treatments and methods" (New York, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,998, issued on Oct. 14, was assigned to The Trustees of Columbia University in the City of New York (New York).

"SLC2A1 lncRNA as a biologic and related treatments and methods" was invented by Umrao Monani (Oradell, N.J.) and Maoxue Tang (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel antisense transcript to the human SLC2A1 (Glut1) gene, variants and fragments thereof. This antisense transcript can be used to modulate Glut1 expression and serve to restore Glut1, and as a therapeutic for treating or preventing Glut 1 deficiency syndrome, or other Glut1 related conditions including certain cancers, di...